Following The Money: Institution’s Growing Stake In Sangamo Therapeutics Inc (NASDAQ: SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Thursday at a closing price of $1.27, with 8.17 million shares of worth about $10.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 28.26% during that period and on February 06, 2025 the price saw a […]
Following The Money: Institution’s Growing Stake In Sangamo Therapeutics Inc (NASDAQ: SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Thursday at a closing price of $1.23, with 6.11 million shares of worth about $7.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 75.71% during that period and on January 30, 2025 the price saw a […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Hogging The Spotlight Today
Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -24.07% and 22.43% over the past three months. SGMO shares are trading 0.49% year to date (YTD), with the 12-month market performance up to 103.05% higher. […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Sangamo Therapeutics Inc (NASDAQ:SGMO) by 1.13%. After grabbing 12.41 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.00% having worth around $5.34 million. […]
